These findings are similar to the inhibition of DNMT1 by miR-155-5p (109), suggesting that CHD RNA and miR-155-5p are potential therapeutic targets that could be used to restore DNMT3A, DNMT1 (107). This evidence concerns the gene DNMT1 and coronary artery disorder.